Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods and devices for follow-up care and treatment of a pneumostoma

a follow-up care and treatment technology, applied in the field of methods and devices for follow-up care and treatment of pneumostoma, can solve the problems of increased exhalation work, significant underdiagnosis of psoriasis, hyperinflation of the lung, etc., to reduce hyperinflation, stabilize the artificial aperture, and shrink the lung

Inactive Publication Date: 2009-08-20
PORTAERO
View PDF104 Cites 42 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0036]In view of the disadvantages of the state of the art, Applicants have developed a method for treating COPD in which an artificial passageway is made through the chest wall into the lung. An anastomosis is formed between the artificial passageway and the lung by pleurodesis between the visceral and parietal membranes surrounding the passageway as it enters the lung. The pleurodesis creates an adhesion between the pleural membrane surrounding the passageway which prevents air from entering the pleural cavity and causing a pneumothorax (deflation of the lung due to air pressure in the pleural cavity). Pleurodesis results from a fibrotic healing response between the pleural membranes and may be localized to the vicinity of the passageway. The artificial passageway through the chest wall also becomes epithelialized. The result is a stable artificial aperture through the chest wall which communicates with the parenchymal tissue of the lung.
[0038]The present invention provides methods and devices for assessing, and treating the health and functionality of a pneumostoma. Utilizing the methods and devices of the present invention a physician can enhance the health, patency and / or effectiveness of a pneumostoma thereby enhancing the remediation of COPD. Other objects, features and advantages of the invention are apparent from drawings and detailed description to follow.

Problems solved by technology

However an additional ten million adults have evidence of impaired lung function indicating that COPD may be significantly underdiagnosed.
This increases the work of exhaling and leads to hyperinflation of the lung.
When the lungs become hyperinflated, forced expiration cannot reduce the residual volume of the lungs because the force exerted to empty the lungs collapses the small airways and blocks air from being exhaled.
With continued exposure to cigarettes or noxious particles, the disease progresses and individuals with COPD increasingly lose their ability to breathe.
Ultimately, severe emphysema may lead to severe dyspnea, severe limitation of daily activities, illness and death.
However, many patients are not candidates for such a taxing procedure.
However, these proposals remain significantly invasive and are still in clinical trails.
None of the surgical approaches to treatment of COPD has been widely adopted.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and devices for follow-up care and treatment of a pneumostoma
  • Methods and devices for follow-up care and treatment of a pneumostoma
  • Methods and devices for follow-up care and treatment of a pneumostoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0070]The following description is of the best modes presently contemplated for practicing various embodiments of the present invention. The description is not to be taken in a limiting sense but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be ascertained with reference to the claims. In the description of the invention that follows, like numerals or reference designators are used to refer to like parts or elements throughout. In addition, the first digit of a reference number identifies the drawing in which the reference number first appears.

Pneumostoma Formation and Anatomy

[0071]FIG. 1A shows the chest of a patient identifying alternative locations for creating a pneumostoma that may be managed using the system of the present invention. A first pneumostoma 110 is shown on the front of the chest 100 over the right lung 101 (shown in dashed lines). The pneumostoma is preferably positioned over the third inter...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma and for additional patient care utilizing a pneumostoma. The system utilizes a number of modalities to assess the health and functionality of the pneumostoma, the lungs and / or the patient as a whole. In response to an assessment of the health and functionality of the pneumostoma, lungs and patient, the tissues of pneumostoma may be treated with a treatment device and utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma and / or treat other conditions of the patient.

Description

CLAIM TO PRIORITY[0001]This application claims priority to all of the following applications including: U.S. Provisional Application No. 61 / 029,830, filed Feb. 19, 2008, entitled “ENHANCED PNEUMOSTOMA MANAGEMENT DEVICE AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE” (Attorney Docket No. LUNG1-06013US0);[0002]U.S. Provisional Application No. 61 / 032,877, filed Feb. 29, 2008, entitled “PNEUMOSTOMA MANAGEMENT SYSTEM AND METHODS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE” (Attorney Docket No. LUNG1-06001US0);[0003]U.S. Provisional Application No. 61 / 038,371, filed Mar. 20, 2008, entitled “SURGICAL PROCEDURE AND INSTRUMENT TO CREATE A PNEUMOSTOMA AND TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE” (Attorney Docket No. LUNG1-06000US0);[0004]U.S. Provisional Application No. 61 / 082,892, filed Jul. 23, 2008, entitled “PNEUMOSTOMA MANAGEMENT SYSTEM HAVING A COSMETIC AND / OR PROTECTIVE COVER” (Attorney Docket No. LUNG1-06008US0);[0005]U.S. Provisional Application No....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61M16/00A61F2/958
CPCA61B2017/00809A61M16/202A61M1/04A61M11/00A61M13/00A61M15/0085A61M15/009A61M15/02A61M16/0816A61M25/02A61M25/04A61M25/10A61M39/02A61M39/0247A61M2039/0252A61M2039/0276A61M2202/0208A61M2202/025A61M2202/064A61M2205/7518A61M2205/7536A61M27/00A61K9/007A61M2205/075A61M11/005A61M11/042A61M16/0833
Inventor TANAKA, DONWIESMAN, JOSHUA P.PLOUGH, DAVID C.
Owner PORTAERO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products